STORI

Infliximab stop in CD

MOTUS

Mesalazine in UC, one or two doses/day

Glutamine and whey protein in CD

Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn’s disease: a randomized controlled trial

CYSIF

Cyclosporin vs infliximab in ASUC

Basiliximab-UC

Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis